Identification, Purification, and Pharmacological Activity Analysis of Desmodus Rotundus Salivary Plasminogen Activator Alpha1 (DSPAα1) Expressed in Transgenic Rabbit Mammary Glands

Overview

Journal Transgenic Res

Specialty Molecular Biology

Date 2022 Jan 16

PMID 35034272

Authors

Ting Zhang

Minya Zhou

Heqing Cai

Kunning Yan

Yiwen Zha

Wenwen Zhuang

Jingyan Liang

Yong Cheng

Affiliations

Soon will be listed here.

Abstract

Desmodus rotundus plasminogen activator alpha 1(DSPAα1) is a thrombolytic protein with advantages, such as a long half-life, high accuracy and specificity for thrombolysis, wide therapeutic window, and no neurotoxicity. To date, DSPAα1 has only been expressed in the Chinese hamster ovary, insect cells, transgenic tobacco plants, and Pichia pastoris. To the best of our knowledge, we are the first to report the expression of DSPAα1 in transgenic rabbit mammary glands, extract the product, and analyze its pharmacology activity. An efficient mammary gland-specific expression vector pCL25/DSPAα1 was transferred to prokaryotic zygotes in rabbits by microinjection to generate six DSPAα1 transgenic rabbits. The recombinant DSPAα1 (rDSPAα1) expression in transgenic rabbit milk was 1.19 ± 0.26 mg/mL. The rDSPAα1 purification protocol included pretreatment, ammonium sulfate precipitation, benzamidine affinity chromatography, cation exchange chromatography, and Cibacron blue affinity chromatography; approximately 98% purity was achieved using gel electrophoresis. According to sequencing results, the primary structure of rDSPAα1 was consistent with the theoretical design sequence, and its molecular weight was consistent with that of the natural protein. N-terminal sequencing results indicated rDSPAα1 to be a mature protein, as the goat signal peptide sequence of the expression vector was no longer detected. The fibrinolytic activity of rDSPAα1 was estimated to be 773,333 IU/mg. Fibrin-agarose plate assay and in vitro rat blood clot degradation assay showed that rDSPAα1 had strong thrombolytic activity. In conclusion, we report recombinant DSPAα1 with high thrombolytic activity expressed in transgenic rabbit mammary glands.

Citing Articles

Expression of a single-chain monellin (MNEI) mutant with enhanced stability in transgenic mice milk.

Lu R, Li X, Hu J, Wang Y, Jin L Transgenic Res. 2024; 33(4):211-218.

PMID: 38858256 DOI: 10.1007/s11248-024-00389-7.

Diverse origins of fibrinolytic enzymes: A comprehensive review.

Hazare C, Bhagwat P, Singh S, Pillai S Heliyon. 2024; 10(5):e26668.

PMID: 38434287 PMC: 10907686. DOI: 10.1016/j.heliyon.2024.e26668.

Comparison of Activity and Safety of DSPAα1 and Its N-Glycosylation Mutants.

Peng H, Wang N, Wang M, Yang C, Guo W, Li G Life (Basel). 2023; 13(4).

PMID: 37109514 PMC: 10145227. DOI: 10.3390/life13040985.

References

Balbas P . Understanding the art of producing protein and nonprotein molecules in Escherichia coli. Mol Biotechnol. 2001; 19(3):251-67. DOI: 10.1385/MB:19:3:251. View

Benchenane K, Lopez-Atalaya J, Fernandez-Monreal M, Touzani O, Vivien D . Equivocal roles of tissue-type plasminogen activator in stroke-induced injury. Trends Neurosci. 2004; 27(3):155-60. DOI: 10.1016/j.tins.2003.12.011. View

Benchenane K, Berezowski V, Ali C, Fernandez-Monreal M, Lopez-Atalaya J, Brillault J . Tissue-type plasminogen activator crosses the intact blood-brain barrier by low-density lipoprotein receptor-related protein-mediated transcytosis. Circulation. 2005; 111(17):2241-9. DOI: 10.1161/01.CIR.0000163542.48611.A2. View

Berg D, Grinnell B . Signal and propeptide processing of human tissue plasminogen activator: activity of a pro-tPA derivative. Biochem Biophys Res Commun. 1991; 179(3):1289-96. DOI: 10.1016/0006-291x(91)91713-m. View

Cheng Y, An L, Yuan Y, Wang Y, Du F, Yu B . Hybrid expression cassettes consisting of a milk protein promoter and a cytomegalovirus enhancer significantly increase mammary-specific expression of human lactoferrin in transgenic mice. Mol Reprod Dev. 2012; 79(8):573-85. DOI: 10.1002/mrd.22063. View

Dyck M, Lacroix D, Pothier F, Sirard M . Making recombinant proteins in animals--different systems, different applications. Trends Biotechnol. 2003; 21(9):394-9. DOI: 10.1016/S0167-7799(03)00190-2. View

Endo A, Nagai N, Urano T, Takada Y, Hashimoto K, Takada A . Proteolysis of neuronal cell adhesion molecule by the tissue plasminogen activator-plasmin system after kainate injection in the mouse hippocampus. Neurosci Res. 1999; 33(1):1-8. DOI: 10.1016/s0168-0102(98)00105-9. View

Furlan A, Eyding D, Albers G, Al-Rawi Y, Lees K, Rowley H . Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke. 2006; 37(5):1227-31. DOI: 10.1161/01.STR.0000217403.66996.6d. View

Gardell S, Duong L, Diehl R, York J, Hare T, Register R . Isolation, characterization, and cDNA cloning of a vampire bat salivary plasminogen activator. J Biol Chem. 1989; 264(30):17947-52. View

10.

Gardell S, Hare T, Bergum P, Cuca G, Zavodny S . Vampire bat salivary plasminogen activator is quiescent in human plasma in the absence of fibrin unlike human tissue plasminogen activator. Blood. 1990; 76(12):2560-4. View

11.

Gohlke M, Nuck R, Kannicht C, Grunow D, Baude G, Donner P . Analysis of site-specific N-glycosylation of recombinant Desmodus rotundus salivary plasminogen activator rDSPA alpha 1 expressed in Chinese hamster ovary cells. Glycobiology. 1997; 7(1):67-77. DOI: 10.1093/glycob/7.1.67. View

12.

Gurewich V . Thrombolysis: A Critical First-Line Therapy with an Unfulfilled Potential. Am J Med. 2015; 129(6):573-5. DOI: 10.1016/j.amjmed.2015.11.033. View

13.

Harada T, Kano T, Katayama Y, Matsuzaki T, Tejima E, Koshinaga M . Tissue plasminogen activator extravasated through the cerebral vessels: evaluation using a rat thromboembolic stroke model. Thromb Haemost. 2005; 94(4):791-6. DOI: 10.1160/TH05-03-0164. View

14.

He Z, Lu R, Zhang T, Jiang L, Zhou M, Wu D . A novel recombinant human plasminogen activator: Efficient expression and hereditary stability in transgenic goats and in vitro thrombolytic bioactivity in the milk of transgenic goats. PLoS One. 2018; 13(8):e0201788. PMC: 6097695. DOI: 10.1371/journal.pone.0201788. View

15.

He Z, Jiang L, Zhang T, Zhou M, Wu D, Yuan T . Efficient increase of the novel recombinant human plasminogen activator expression level and stability through the use of homozygote transgenic rabbits. Int J Mol Med. 2018; 42(4):2269-2275. DOI: 10.3892/ijmm.2018.3754. View

16.

Jindal H, Merchant E, Balschi J, Zhangand Y, Koren G . Proteomic analyses of transgenic LQT1 and LQT2 rabbit hearts elucidate an increase in expression and activity of energy producing enzymes. J Proteomics. 2012; 75(17):5254-65. PMC: 4386689. DOI: 10.1016/j.jprot.2012.06.034. View

17.

Kaur J, Zhao Z, Klein G, Lo E, Buchan A . The neurotoxicity of tissue plasminogen activator?. J Cereb Blood Flow Metab. 2004; 24(9):945-63. DOI: 10.1097/01.WCB.0000137868.50767.E8. View

18.

Kratzschmar J, Haendler B, Langer G, Boidol W, Bringmann P, Alagon A . The plasminogen activator family from the salivary gland of the vampire bat Desmodus rotundus: cloning and expression. Gene. 1991; 105(2):229-37. DOI: 10.1016/0378-1119(91)90155-5. View

19.

Kratzschmar J, Haendler B, Bringmann P, Dinter H, Hess H, Donner P . High-level secretion of the four salivary plasminogen activators from the vampire bat Desmodus rotundus by stably transfected baby hamster kidney cells. Gene. 1992; 116(2):281-4. DOI: 10.1016/0378-1119(92)90526-u. View

20.

Liberatore G, Samson A, Bladin C, Schleuning W, Medcalf R . Vampire bat salivary plasminogen activator (desmoteplase): a unique fibrinolytic enzyme that does not promote neurodegeneration. Stroke. 2003; 34(2):537-43. DOI: 10.1161/01.str.0000049764.49162.76. View